drugset / Trial / NCT01757899
Effects and Safety of Infusion of Low-Doses of Methylprednisolone in Early ALI and ARDS in Children
Phase 2
Withdrawn
Federal University of Rio de Janeiro
Instituto D'Or de Pesquisa · collabInstituto de Puericultura e Pediatria Martagão Gesteira - IPPMG/UFRJ · collabRio de Janeiro State Research Supporting Foundation (FAPERJ) · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to investigate the effects of prolonged low-dose methylprednisolone infusion on pulmonary function (LIS and ventilation-free days), extra pulmonary organ function (PMODS score), inflammatory markers - RCP (Reactive C Protein), IL6 (Interleukine 6), TNFα (Tumor Necrosis Factor), IL8 (Interleukine 8), IL10 (Interleukine 10) and length of Pediatric Intensive Care Unit (PICU) stay in early ALI/ARDS in children.
Timeline
- Start
- 2014-01
- Primary completion
- 2016-01
- Completion
- 2016-01
Outcome
Outcome not reported
Stopped: “Technical problems”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Methylprednisolone | Other / unclassified | 1 mg/kg | Intravenous |